EP0669855B1 - Device for collection and processing of biological samples - Google Patents
Device for collection and processing of biological samples Download PDFInfo
- Publication number
- EP0669855B1 EP0669855B1 EP93925163A EP93925163A EP0669855B1 EP 0669855 B1 EP0669855 B1 EP 0669855B1 EP 93925163 A EP93925163 A EP 93925163A EP 93925163 A EP93925163 A EP 93925163A EP 0669855 B1 EP0669855 B1 EP 0669855B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- chamber
- container
- stopper
- passage
- wall
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000012545 processing Methods 0.000 title description 9
- 239000012472 biological sample Substances 0.000 title description 4
- 239000012530 fluid Substances 0.000 claims abstract description 14
- 239000012528 membrane Substances 0.000 claims description 18
- 238000007789 sealing Methods 0.000 claims description 13
- 238000004891 communication Methods 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 12
- 239000007787 solid Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- 230000000717 retained effect Effects 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 abstract description 40
- 239000008280 blood Substances 0.000 abstract description 40
- 239000012141 concentrate Substances 0.000 abstract description 12
- 244000005700 microbiome Species 0.000 abstract description 12
- 230000001413 cellular effect Effects 0.000 abstract description 7
- 238000012360 testing method Methods 0.000 abstract description 5
- 239000000523 sample Substances 0.000 description 14
- 239000003153 chemical reaction reagent Substances 0.000 description 11
- 238000005119 centrifugation Methods 0.000 description 6
- 230000009089 cytolysis Effects 0.000 description 5
- 210000003743 erythrocyte Anatomy 0.000 description 5
- 210000000265 leukocyte Anatomy 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 4
- 239000012569 microbial contaminant Substances 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 238000011109 contamination Methods 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 229920001821 foam rubber Polymers 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- -1 for example Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 229920001463 polyanetholesulfonic acid sodium salt Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000011152 fibreglass Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000003566 sealing material Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/491—Blood by separating the blood components
Definitions
- This invention relates to devices and methods for collecting and processing of biological samples, such as, for example, blood and serum samples. More particularly, this invention relates to an apparatus for the collection and processing of biological samples which does not require centrifugation of the sample.
- Biological samples such as blood and serum samples, for example, are often tested for microbial infections.
- blood may be collected in a sample tube which contains a reagent which causes lysis of red and white blood cells, but not of microbial contaminants.
- the tube is then placed in a centrifuge. Centrifugation results in the separation of the sample into a supernatant and a concentrate which contains cellular debris and microbial contaminants, if present.
- the supernatant is removed from the sample, and the remaining concentrate is then tested for the presence of microbial contaminants, generally by streaking such concentrate onto a culture plate, and incubating the culture.
- a container which comprises a first chamber and a second chamber.
- the container is under vacuum.
- the container also includes a first means for selectively placing the first chamber in fluid flow communication with the second chamber, and a second means for introducing material i.e. a mixture of solids and liquid into the first chamber without releasing the vacuum of the second chamber.
- the container further includes a retaining means in the first chamber for retaining the solid component of a mixture of solids and liquid which is introduced into the first chamber, and means for selectively placing the interior of the container in communication with the atmosphere outside the container. After introduction of a mixture into the container, liquid passes through the retaining means and through the first means for selectively placing the first chamber in fluid flow communication with the second chamber with the solid component being retained on the retaining means.
- the second chamber surrounds the first chamber and is concentric with the first chamber.
- the first chamber is defined by an inner wall
- the second chamber is defined by the inner wall and an outer wall. The inner wall protrudes above the top of the second chamber.
- the first means for selectively placing the first chamber in fluid flow communication with the second chamber comprises a lower stopper fitting within a bottom opening of the container.
- the stopper includes a lower passage communicating with the first chamber, and a passage in the inner wall adjacent the second chamber.
- the lower passage of the lower stopper is capable of being aligned with the passage of the inner wall adjacent the second chamber to provide for the flow of liquid from the first chamber to the second chamber.
- the retaining means includes a membrane, which is disposed across the lower passage of the lower stopper which communicates with the first chamber. More preferably, the lower stopper includes a lower portion and an upper insert portion which includes the passage communicating with the first chamber. In one alternative embodiment, the passage has a inverted conical shape, whereby the liquid is funneled from the inner chamber toward the second, or outer chamber. The upper insert portion also includes the membrane disposed across the lower passage communicating with the first chamber.
- the means for selectively placing the interior of the container in communication with the atmosphere outside the container includes an upper stopper fitting within a top opening of the container.
- the upper stopper includes an upper passage communicating with the first chamber.
- the means for selectively placing the interior of the container in communication with the outside atmosphere also includes an opening in the inner wall above the top of the second chamber.
- the upper passage of the upper stopper is capable of being aligned with the opening in the inner wall to release the vacuum and provide for the passage of air from the outside atmosphere into the container.
- the upper stopper also includes the second means for introducing material into the first chamber.
- the upper stopper includes an upper portion and a lower portion.
- the lower portion fits within the top opening of the container.
- the lower portion includes the upper passage communicating with the first chamber.
- the second means for introducing material into the first chamber without releasing the vacuum of the second chamber is a first self-sealing portion included in the upper portion of the stopper, and a second self-sealing portion included in the lower portion of the stopper.
- the second self-sealing portion is a one-way valve fitting within the first chamber.
- an airtight layer is placed between the upper and lower portions of the upper stopper.
- the airtight layer may be, for example, a laminated foil which is laminated to the underside of the upper portion of the upper stopper.
- the lower portion of the upper stopper also has an airtight layer laminated to its bottom.
- a thick rubber wall is attached to the underside of the upper portion of the stopper.
- a sterile filter layer is placed between the upper and lower portions of the upper stopper.
- a sterile filter plug is contained within the lower portion of the upper stopper.
- the sterile filter plug is made of a porous material such as, for example, cotton, foam rubber, sintered polyethylene, aluminum oxide, sintered glass, or fiberglass.
- the porosity of the sterile filter plug should be such that the filter plug allows the passage of air through the filter plug yet is able to trap contaminants such as microorganisms within the filter plug.
- the filter plug also permits the insertion of a conduit, such as an injection needle, through the filter plug, and the withdrawal of such a conduit from the filter plug while maintaining the structural integrity of the filter plug.
- the upper portion of the upper stopper is removable from the lower portion.
- the container of the present invention is particularly applicable to the collection and processing of blood samples for testing for microbial contamination.
- a blood sample may be introduced into the first, or inner chamber via a syringe needle inserted through the self-sealing portion(s) of the upper stopper.
- the upper and lower stoppers are in the closed position.
- Contained in the inner chamber is a reagent which lyses red and white blood cells but not microbial contaminants.
- a reagent is the IsolatorTM 10 reagent (Carter-Wallace, Inc.), which contains saponin, polypropylene glycol, sodium polyanethole sulfonate (SPS), and ethylenediamine tetraacetic acid (EDTA).
- the upper and lower stoppers are moved to the open position.
- air is drawn through the opening in the wall of the first, or inner chamber above the top of the outer chamber, through the upper passage of the upper stopper, and into the inner chamber.
- the air pressure forces the blood through the membrane of the lower stopper, through the lower passage of the lower stopper, and through the opening of the wall of the inner chamber which is adjacent the second, or outer chamber, whereby blood flows into the outer chamber.
- an upper stopper which includes a filter plug contained in the lower portion
- the removal of the upper portion of the upper stopper from the lower portion of the upper stopper enables air to pass through the filter plug and into the inner chamber, whereby the passage of air into the inner chamber enables blood to flow from the inner chamber to the outer chamber.
- Cellular debris and contaminating microorganisms, if present, are trapped by the membrane.
- a pipette may then be inserted through the upper stopper to remove the blood, cellular debris, and microorganisms, if present, from the inner chamber.
- This blood sample which is analogous to a concentrate obtained in a centrifugation procedure, may then be subjected to testing for microbial contamination.
- the container 10 includes a top opening A and a bottom opening B.
- Container 10 includes an inner wall 12 and an outer wall 14, which define a first, or inner chamber 13 and a second, or outer chamber 15.
- Inner wall 12 and outer wall 14 merge at the top of outer chamber 15, thereby sealing outer chamber 15 at its top end.
- Inner wall 12 protrudes above the top of outer chamber 15.
- An opening 16, covered by a 0.2 ⁇ membrane 17 is located in inner wall 12 above the top of outer chamber 15.
- Membrane 17 allows the passage of air through opening 16, but prevents the passage of particles and contaminating microorganisms.
- a passage 18 is located on inner wall 12 adjacent outer chamber 15. Passage 18, which may be in the form of an opening or a notch, provides for the passage of air or liquid between inner chamber 13 and outer chamber 15.
- Upper stopper 20 Fitting within the top opening A of container 10 is upper stopper 20.
- Upper stopper 20 includes an upper portion 22 and a lower portion 24.
- Upper portion 22 includes a self-sealing center 21, made of a self-sealing material such as rubber, and an airtight layer 23 on the underside of upper portion 22.
- the airtight layer may be made of any of a variety of materials, such as foil.
- the lower portion 24 includes a self-sealing one-way valve 25, and an opening 26. Opening 26 may be aligned with opening 16 in inner wall 12 to provide for the passage of air through lower portion 24 of upper stopper 20, and into inner chamber 13.
- Bottom stopper 30 includes an upper insert portion 32 which fits within lower portion 34. Disposed at the top of upper insert portion 32 is a 0.2 ⁇ membrane 31. Membrane 31 allows the passage of liquid components of blood into passage 35, but prevents the passage of cellular debris and microorganisms. Upper insert portion 32 also includes an opening 33. Opening 33 may be aligned with passage 18, thereby allowing the fluid portion of blood to pass from inner chamber 13 through membrane 31, passage 35, opening 33, and passage 18 into outer chamber 15.
- the container 10 is employed for the collection of blood as follows.
- Upper stopper 20 is positioned within top opening A of container 10 such that opening 26 is not aligned with opening 16 of inner wall 12.
- Lower stopper 30 is positioned within bottom opening B of container 10 such that opening 33 is not aligned with passage 18 of inner wall 12.
- a reagent 19 which causes lysis of red and white blood cells is contained within inner chamber 13. Reagent 19 settles on top of membrane 31 within inner chamber 13 due to gravity.
- a specimen such as a blood sample
- a specimen is injected into inner chamber 13 by means of an injection needle inserted through self-sealing centers 21 and 25.
- the blood is admixed with reagent 19 in inner chamber 13, and the blood is reacted with reagent 19 for a period of time sufficient to cause lysis of red and white blood cells.
- reaction time may be from about 1 minute to about 5 hours.
- Reagent 19, however, will not cause lysis of contaminating microorganisms.
- upper stopper 20 Upon reaction of the blood with reagent 19 to cause lysis of red and white blood cells, upper stopper 20 is turned within top opening A such that opening 26 is aligned with opening 16, and bottom stopper 30 is turned such that opening 33 is aligned with passage 18.
- Air pressure caused by air passing through membrane 17, and openings 16 and 26 into inner chamber 13 enables the fluid portion of the blood to pass through membrane 31, passage 35, opening 33, and passage 18 into outer chamber 15.
- the container 10 is operated such that a portion of the blood will remain in inner chamber 13. If the volume of blood placed in inner chamber 13 is greater than the total volume of outer chamber 15, the blood will flow from inner chamber 13 to outer chamber 15 until outer chamber 15 is filled.
- the blood is allowed to flow from inner chamber 13 to outer chamber 15 until a specified volume of blood remains in inner chamber 13.
- the indication of such volume being shown in the form of markings (not shown) on container 10, the bottom stopper 30 is turned from the open position to a closed position in which opening 33 is not aligned with passage 18.
- the portion of the blood sample which remains in inner chamber 13 is a concentrate of fluid components of blood, cellular debris, and microorganisms, if present.
- This concentrate may then be withdrawn from the inner chamber 13.
- the tube Prior to withdrawal of the concentrate, the tube is vortexed briefly (eg., about 10 seconds).
- the upper portion 22 of upper stopper 20 is removed from lower portion 24 to expose the self-sealing center 25.
- a collection tube, such as a pipette is inserted through center 25, and into inner chamber 13.
- the pipette is inserted into inner chamber 13 to a point just above membrane 31.
- the concentrate is then withdrawn from inner chamber 13 into the pipette, from which the concentrate may be dispensed onto a culture medium to determine the presence of contaminating microorganisms.
- an upper stopper 120 having an upper portion 122, and lower portion 124.
- Upper portion 122 includes a self-sealing center 121.
- Lower portion 124 which fits within inner chamber 113, includes one-way valve 125, which prevents backflow of fluid in inner chamber 113.
- Contained within lover portion 124 is a sterile filter plug 128.
- Filter plug 128 is made of a porous material such as cotton or foam rubber.
- Filter plug 128 also entraps contaminants contained in the air, such as microorganisms. Subsequent to the passage of the blood sample from inner chamber 113 to outer chamber 115, the filter plug 128 may be removed from the lower portion 124 so as to accommodate the insertion of a pipette or other collection tube through lower portion 124 for withdrawal of a concentrate from inner chamber 113.
- lower stopper 230 is provided with an upper insert portion 232 and a lower portion 234.
- Upper insert portion 232 which fits within inner chamber 213 and into lower portion 234, includes a membrane 231 disposed above an inverted conical passage 235. Near the apex of conical passage 235 is an opening 233, which may be aligned with passage 218 in inner wall 212, thereby allowing the passage of the fluid components of blood from inner chamber 213 to outer chamber 215.
- Upper insert portion 232 also includes a groove 237, which mates with notch 238 of lower portion 234 to provide a secure fitting of upper insert portion 232 within lower portion 234.
- Advantages of the present invention include the ability to provide a concentrate of a fluid portion of blood which contains cellular debris and contaminating microorganisms, if present, without subjecting a blood sample to time-consuming and expensive centrifugation techniques.
- the collection and processing of a blood sample with the device of the present invention may be accomplished in about 5 minutes, whereas collecting and processing of a blood sample using conventional centrifugation techniques may take 45 minutes or more.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Ecology (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Clinical Laboratory Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Sampling And Sample Adjustment (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
- This invention relates to devices and methods for collecting and processing of biological samples, such as, for example, blood and serum samples. More particularly, this invention relates to an apparatus for the collection and processing of biological samples which does not require centrifugation of the sample.
- Biological samples, such as blood and serum samples, for example, are often tested for microbial infections. In general, blood may be collected in a sample tube which contains a reagent which causes lysis of red and white blood cells, but not of microbial contaminants. The tube is then placed in a centrifuge. Centrifugation results in the separation of the sample into a supernatant and a concentrate which contains cellular debris and microbial contaminants, if present. The supernatant is removed from the sample, and the remaining concentrate is then tested for the presence of microbial contaminants, generally by streaking such concentrate onto a culture plate, and incubating the culture.
- Such processing procedures, however, require an appreciable amount of equipment and expense, as well as a considerable amount of time. The collection and processing of a blood sample for testing for microbial contamination may require a period of time of up to 45 minutes.
- It is therefore an object of the present invention to provide an apparatus for the collection and processing of blood for further testing without the time and expense involved in centrifugation.
- In accordance with an aspect of the present invention, there is provided a container which comprises a first chamber and a second chamber. The container is under vacuum. The container also includes a first means for selectively placing the first chamber in fluid flow communication with the second chamber, and a second means for introducing material i.e. a mixture of solids and liquid into the first chamber without releasing the vacuum of the second chamber. The container further includes a retaining means in the first chamber for retaining the solid component of a mixture of solids and liquid which is introduced into the first chamber, and means for selectively placing the interior of the container in communication with the atmosphere outside the container. After introduction of a mixture into the container, liquid passes through the retaining means and through the first means for selectively placing the first chamber in fluid flow communication with the second chamber with the solid component being retained on the retaining means.
- In a preferred embodiment, the second chamber surrounds the first chamber and is concentric with the first chamber. The first chamber is defined by an inner wall, and the second chamber is defined by the inner wall and an outer wall. The inner wall protrudes above the top of the second chamber.
- In one embodiment, the first means for selectively placing the first chamber in fluid flow communication with the second chamber comprises a lower stopper fitting within a bottom opening of the container. The stopper includes a lower passage communicating with the first chamber, and a passage in the inner wall adjacent the second chamber. The lower passage of the lower stopper is capable of being aligned with the passage of the inner wall adjacent the second chamber to provide for the flow of liquid from the first chamber to the second chamber.
- In one preferred embodiment, the retaining means includes a membrane, which is disposed across the lower passage of the lower stopper which communicates with the first chamber. More preferably, the lower stopper includes a lower portion and an upper insert portion which includes the passage communicating with the first chamber. In one alternative embodiment, the passage has a inverted conical shape, whereby the liquid is funneled from the inner chamber toward the second, or outer chamber. The upper insert portion also includes the membrane disposed across the lower passage communicating with the first chamber.
- In another embodiment, the means for selectively placing the interior of the container in communication with the atmosphere outside the container includes an upper stopper fitting within a top opening of the container. The upper stopper includes an upper passage communicating with the first chamber. The means for selectively placing the interior of the container in communication with the outside atmosphere also includes an opening in the inner wall above the top of the second chamber. The upper passage of the upper stopper is capable of being aligned with the opening in the inner wall to release the vacuum and provide for the passage of air from the outside atmosphere into the container. Preferably, the upper stopper also includes the second means for introducing material into the first chamber.
- In a preferred embodiment, the upper stopper includes an upper portion and a lower portion. The lower portion fits within the top opening of the container. The lower portion includes the upper passage communicating with the first chamber. The second means for introducing material into the first chamber without releasing the vacuum of the second chamber is a first self-sealing portion included in the upper portion of the stopper, and a second self-sealing portion included in the lower portion of the stopper. In one embodiment, the second self-sealing portion is a one-way valve fitting within the first chamber.
- In another embodiment, an airtight layer is placed between the upper and lower portions of the upper stopper. The airtight layer may be, for example, a laminated foil which is laminated to the underside of the upper portion of the upper stopper. In another embodiment, the lower portion of the upper stopper also has an airtight layer laminated to its bottom. In yet another embodiment, a thick rubber wall is attached to the underside of the upper portion of the stopper.
- In another alternative, a sterile filter layer is placed between the upper and lower portions of the upper stopper.
- In yet another alternative, a sterile filter plug is contained within the lower portion of the upper stopper. The sterile filter plug is made of a porous material such as, for example, cotton, foam rubber, sintered polyethylene, aluminum oxide, sintered glass, or fiberglass. The porosity of the sterile filter plug should be such that the filter plug allows the passage of air through the filter plug yet is able to trap contaminants such as microorganisms within the filter plug. The filter plug also permits the insertion of a conduit, such as an injection needle, through the filter plug, and the withdrawal of such a conduit from the filter plug while maintaining the structural integrity of the filter plug. In such an embodiment, the upper portion of the upper stopper is removable from the lower portion. When the upper portion of the upper stopper is removed from the lower portion, the lower portion of the upper stopper and the sterile filter plug contained within the lower portion are exposed to the surrounding atmosphere. Air passes through the filter plug contained in the lower portion of the upper stopper and into the inner chamber. Such an embodiment, therefore, does not require alignable openings in the upper stopper and in the wall of the upper chamber.
- The container of the present invention is particularly applicable to the collection and processing of blood samples for testing for microbial contamination. A blood sample may be introduced into the first, or inner chamber via a syringe needle inserted through the self-sealing portion(s) of the upper stopper. The upper and lower stoppers are in the closed position. Contained in the inner chamber is a reagent which lyses red and white blood cells but not microbial contaminants. An example of such a reagent is the
Isolator™ 10 reagent (Carter-Wallace, Inc.), which contains saponin, polypropylene glycol, sodium polyanethole sulfonate (SPS), and ethylenediamine tetraacetic acid (EDTA). Once the blood has reacted with the reagent, the upper and lower stoppers are moved to the open position. When the stoppers are moved to the open position, air is drawn through the opening in the wall of the first, or inner chamber above the top of the outer chamber, through the upper passage of the upper stopper, and into the inner chamber. The air pressure forces the blood through the membrane of the lower stopper, through the lower passage of the lower stopper, and through the opening of the wall of the inner chamber which is adjacent the second, or outer chamber, whereby blood flows into the outer chamber. Alternatively, when an upper stopper which includes a filter plug contained in the lower portion is employed, the removal of the upper portion of the upper stopper from the lower portion of the upper stopper enables air to pass through the filter plug and into the inner chamber, whereby the passage of air into the inner chamber enables blood to flow from the inner chamber to the outer chamber. Cellular debris and contaminating microorganisms, if present, are trapped by the membrane. A small portion of the blood remains in the inner chamber. A pipette may then be inserted through the upper stopper to remove the blood, cellular debris, and microorganisms, if present, from the inner chamber. This blood sample, which is analogous to a concentrate obtained in a centrifugation procedure, may then be subjected to testing for microbial contamination. - The invention will now be described with respect to the drawings, wherein:
- Figure 1 is a cross-sectional view of an embodiment of the container of the present invention;
- Figure 2 is a cross-sectional view of the container;
- Figure 3 is a cross-sectional view of an alternative embodiment of the upper stopper of the container; and
- Figure 4 is an exploded view of an alternative embodiment of the lower stopper of the container.
- Referring now to the drawings, the
container 10 includes a top opening A and a bottomopening B. Container 10 includes aninner wall 12 and anouter wall 14, which define a first, orinner chamber 13 and a second, orouter chamber 15.Inner wall 12 andouter wall 14 merge at the top ofouter chamber 15, thereby sealingouter chamber 15 at its top end.Inner wall 12 protrudes above the top ofouter chamber 15. Anopening 16, covered by a 0.2µ membrane 17 is located ininner wall 12 above the top ofouter chamber 15.Membrane 17 allows the passage of air throughopening 16, but prevents the passage of particles and contaminating microorganisms. Apassage 18 is located oninner wall 12 adjacentouter chamber 15.Passage 18, which may be in the form of an opening or a notch, provides for the passage of air or liquid betweeninner chamber 13 andouter chamber 15. - Fitting within the top opening A of
container 10 isupper stopper 20.Upper stopper 20 includes anupper portion 22 and alower portion 24.Upper portion 22 includes a self-sealingcenter 21, made of a self-sealing material such as rubber, and anairtight layer 23 on the underside ofupper portion 22. The airtight layer may be made of any of a variety of materials, such as foil. Thelower portion 24 includes a self-sealing one-way valve 25, and anopening 26.Opening 26 may be aligned with opening 16 ininner wall 12 to provide for the passage of air throughlower portion 24 ofupper stopper 20, and intoinner chamber 13. - Fitting within bottom opening B of
container 10 isbottom stopper 30.Bottom stopper 30 includes anupper insert portion 32 which fits withinlower portion 34. Disposed at the top ofupper insert portion 32 is a 0.2µ membrane 31.Membrane 31 allows the passage of liquid components of blood intopassage 35, but prevents the passage of cellular debris and microorganisms.Upper insert portion 32 also includes anopening 33.Opening 33 may be aligned withpassage 18, thereby allowing the fluid portion of blood to pass frominner chamber 13 throughmembrane 31,passage 35, opening 33, andpassage 18 intoouter chamber 15. - The
container 10 is employed for the collection of blood as follows.Upper stopper 20 is positioned within top opening A ofcontainer 10 such thatopening 26 is not aligned with opening 16 ofinner wall 12.Lower stopper 30 is positioned within bottom opening B ofcontainer 10 such thatopening 33 is not aligned withpassage 18 ofinner wall 12. Such positioning of the upper andlower stoppers inner chamber 13 andouter chamber 15 ofcontainer 10, which was created during the manufacturing and assembly of the device. Areagent 19 which causes lysis of red and white blood cells is contained withininner chamber 13.Reagent 19 settles on top ofmembrane 31 withininner chamber 13 due to gravity. For specimen collection, a specimen, such as a blood sample, is injected intoinner chamber 13 by means of an injection needle inserted through self-sealingcenters reagent 19 ininner chamber 13, and the blood is reacted withreagent 19 for a period of time sufficient to cause lysis of red and white blood cells. Such reaction time may be from about 1 minute to about 5 hours.Reagent 19, however, will not cause lysis of contaminating microorganisms. - Upon reaction of the blood with
reagent 19 to cause lysis of red and white blood cells,upper stopper 20 is turned within top opening A such thatopening 26 is aligned with opening 16, andbottom stopper 30 is turned such thatopening 33 is aligned withpassage 18. Air pressure caused by air passing throughmembrane 17, andopenings inner chamber 13 enables the fluid portion of the blood to pass throughmembrane 31,passage 35, opening 33, andpassage 18 intoouter chamber 15. Thecontainer 10 is operated such that a portion of the blood will remain ininner chamber 13. If the volume of blood placed ininner chamber 13 is greater than the total volume ofouter chamber 15, the blood will flow frominner chamber 13 toouter chamber 15 untilouter chamber 15 is filled. If the total volume ofouter chamber 15 is greater than the volume of blood placed ininner chamber 13, the blood is allowed to flow frominner chamber 13 toouter chamber 15 until a specified volume of blood remains ininner chamber 13. When the specified volume of blood is remaining ininner chamber 13, the indication of such volume being shown in the form of markings (not shown) oncontainer 10, thebottom stopper 30 is turned from the open position to a closed position in whichopening 33 is not aligned withpassage 18. - The portion of the blood sample which remains in
inner chamber 13 is a concentrate of fluid components of blood, cellular debris, and microorganisms, if present. This concentrate may then be withdrawn from theinner chamber 13. Prior to withdrawal of the concentrate, the tube is vortexed briefly (eg., about 10 seconds). Theupper portion 22 ofupper stopper 20 is removed fromlower portion 24 to expose the self-sealingcenter 25. A collection tube, such as a pipette, is inserted throughcenter 25, and intoinner chamber 13. The pipette is inserted intoinner chamber 13 to a point just abovemembrane 31. The concentrate is then withdrawn frominner chamber 13 into the pipette, from which the concentrate may be dispensed onto a culture medium to determine the presence of contaminating microorganisms. - In one alternative, as shown in Figure 3, there is provided an
upper stopper 120 having anupper portion 122, andlower portion 124.Upper portion 122 includes a self-sealingcenter 121.Lower portion 124, which fits withininner chamber 113, includes one-way valve 125, which prevents backflow of fluid ininner chamber 113. Contained withinlover portion 124 is asterile filter plug 128.Filter plug 128 is made of a porous material such as cotton or foam rubber. Whenupper portion 122 ofupper stopper 120 is removed fromlower portion 124, air passes throughfilter plug 128 through one-way valve 125; and intoinner chamber 113; whereby the blood sample contained ininner chamber 113 may pass toouter chamber 115.Filter plug 128 also entraps contaminants contained in the air, such as microorganisms. Subsequent to the passage of the blood sample frominner chamber 113 toouter chamber 115, thefilter plug 128 may be removed from thelower portion 124 so as to accommodate the insertion of a pipette or other collection tube throughlower portion 124 for withdrawal of a concentrate frominner chamber 113. - In another alternative, as shown in Figure 4,
lower stopper 230 is provided with anupper insert portion 232 and alower portion 234.Upper insert portion 232, which fits withininner chamber 213 and intolower portion 234, includes amembrane 231 disposed above an invertedconical passage 235. Near the apex ofconical passage 235 is anopening 233, which may be aligned withpassage 218 ininner wall 212, thereby allowing the passage of the fluid components of blood frominner chamber 213 toouter chamber 215.Upper insert portion 232 also includes agroove 237, which mates withnotch 238 oflower portion 234 to provide a secure fitting ofupper insert portion 232 withinlower portion 234. - Advantages of the present invention include the ability to provide a concentrate of a fluid portion of blood which contains cellular debris and contaminating microorganisms, if present, without subjecting a blood sample to time-consuming and expensive centrifugation techniques. The collection and processing of a blood sample with the device of the present invention may be accomplished in about 5 minutes, whereas collecting and processing of a blood sample using conventional centrifugation techniques may take 45 minutes or more.
- It is to be understood, however, that the scope of the present invention is not to be limited to the specific embodiments described above. The invention may be practiced other than as particularly described and still be within the scope of the accompanying claims.
Claims (11)
- A container (10), comprising:a first chamber (13); anda second chamber (15), said container being under vacuum;a first means (18, 33) for selectively placing the first chamber in fluid flow communication with said second chamber;a second means (21, 25) for introducing a mixture of solids and liquid into the first chamber without releasing the vacuum of said second chamber;retaining means (31) in the first chamber for retaining the solid component of a mixture of solids and liquid which is introduced into the first chamber;means (16, 26) for selectively placing the interior of the first chamber in communication with the atmosphere outside said container, whereby after introduction of a mixture into said container, liquid passes through the retaining means and through said first means for selectively placing the first chamber in fluid flow communication with the second chamber, and into said second chamber with the solid component being retained on said retaining means.
- The container of Claim 1 wherein said second chamber (15) surrounds said first chamber (13) and is concentric with said first chamber, and wherein said first chamber is defined by an inner wall (12) and said second chamber is defined by said inner wall and an outer wall (14), and wherein said inner wall protrudes above the top of said second chamber.
- The container of Claim 2 wherein said first means for selectively placing the first chamber in fluid flow communication with said second chamber comprises a lower stopper fitting (30) within a bottom opening (B) of said container, said stopper including a lower passage (33) communicating with said first chamber, and a passage (18) in said inner wall adjacent said second chamber, wherein said lower passage of said lower stopper is capable of being aligned with said passage of said inner wall adjacent said second chamber to provide for the flow of liquid from said first chamber to said second chamber.
- The container of Claim 2 wherein said means for selectively placing the interior of the container in communication with the atmosphere outside said container includes an upper stopper fitting (20) within a top opening of said container, said upper stopper including an upper passage (26) communicating with said first chamber; and an opening (16) in said inner wall above the top of said second chamber, wherein said upper passage of said upper stopper is capable of being aligned with said opening in said inner wall to provide for the passage of air from the outside atmosphere into said container.
- The container of Claim 4 wherein said upper stopper includes said second means for introducing said mixture of solids and liquid into the first chamber, without releasing the vacuum of said second chamber.
- The container of Claim 3 wherein said retaining means includes a membrane (31) disposed across said lower passage of said lower stopper which communicates with said first chamber.
- The container of Claim 4, and further comprising a membrane (17) disposed across said opening (16) in said inner wall of said container, said membrane providing for the passage of air through said opening in said inner wall while preventing the passage of solid matter therethrough.
- The container of Claim 6 wherein lower stopper includes a lower portion (34) and an upper insert portion (32) fitting within said lower portion and within said first chamber, said upper insert portion including said passage communicating with said first chamber; and said upper insert portion including said membrane disposed across said passage communicating with said first chamber.
- The container of Claim, 5 wherein said upper stopper includes an upper portion (22) and a lower portion (24), said lower portion fitting within the top opening of said container, said lower portion including said upper passage communicating with said first chamber, and wherein said second means for introducing said mixture into the first chamber without releasing the vacuum of the second chamber is a first self-sealing portion included in said upper portion of said stopper and a second self-sealing portion included in said lower portion of said upper stopper.
- The container of Claim 9 wherein said second self-sealing portion is a one-way valve (25) fitting within said first chamber.
- The container of Claim 2 wherein said means for selectively placing the interior of the container in communication with the atmosphere outside said container includes an upper stopper (120) fitting within a top opening of said container, said upper stopper including an upper portion (122) and a lower portion (124), said lower portion fitting within the top opening of said container and said lower portion including a porous filter plug (128), and wherein said second means for introducing said mixture into the first chamber without releasing the vacuum of the second chamber is a first self-sealing portion (121) included in said upper portion of said stopper and a second self-sealing portion (125) included in said lower portion of said upper stopper, and wherein said upper portion of said upper stopper is removable from said lower portion, whereby upon removal of said upper portion from said lower portion, air is enabled to pass through said filter plug and said second self-sealing portion into said first chamber.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/973,734 US5316731A (en) | 1992-11-09 | 1992-11-09 | Device for collection and processing of biological samples |
US973734 | 1992-11-09 | ||
PCT/US1993/010578 WO1994011107A1 (en) | 1992-11-09 | 1993-11-02 | Device for collection and processing of biological samples |
Publications (3)
Publication Number | Publication Date |
---|---|
EP0669855A1 EP0669855A1 (en) | 1995-09-06 |
EP0669855A4 EP0669855A4 (en) | 1996-02-14 |
EP0669855B1 true EP0669855B1 (en) | 1997-03-12 |
Family
ID=25521176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP93925163A Expired - Lifetime EP0669855B1 (en) | 1992-11-09 | 1993-11-02 | Device for collection and processing of biological samples |
Country Status (11)
Country | Link |
---|---|
US (1) | US5316731A (en) |
EP (1) | EP0669855B1 (en) |
JP (1) | JP3286919B2 (en) |
AT (1) | ATE149880T1 (en) |
AU (1) | AU667760B2 (en) |
CA (1) | CA2146257C (en) |
DE (1) | DE69308875T2 (en) |
DK (1) | DK0669855T3 (en) |
ES (1) | ES2099984T3 (en) |
GR (1) | GR3023338T3 (en) |
WO (1) | WO1994011107A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0778841A1 (en) * | 1994-08-29 | 1997-06-18 | Akzo Nobel N.V. | Device for use in the isolation of a biological material such as nucleic acid |
JP3664286B2 (en) * | 1996-12-24 | 2005-06-22 | 富士写真フイルム株式会社 | Blood filtration unit |
DE19726268A1 (en) * | 1997-06-20 | 1999-01-21 | Connex Ges Zur Optimierung Von | Device for taking and examining samples |
US6866826B2 (en) * | 2000-12-30 | 2005-03-15 | Beckman Coulter, Inc. | Large mouth centrifuge labware |
FR2829500B1 (en) * | 2001-09-13 | 2003-12-12 | Hemosystem | PROCESS FOR THE CONCENTRATION AND DETECTION OF PATHOGENIC SPROUTS FROM BLOOD PRODUCTS AND / OR DERIVATIVES THEREOF AND DEVICE FOR CARRYING OUT SAID METHOD |
WO2003054552A2 (en) * | 2001-10-19 | 2003-07-03 | Monogen, Inc. | Automated system and method for processing specimens to extract samples for both liquid-based and slide-based testing |
WO2007064233A1 (en) * | 2005-11-29 | 2007-06-07 | Sharpin Rosemary Katherine Cam | Micro organism testing device |
FR2901281B1 (en) * | 2006-05-19 | 2008-08-15 | Hemosystem Sa | PROCESS FOR EXTRACTING DESOXYRIBONUCLEIC ACIDS (DNA) FROM MICROORGANISMS WHICH MAY BE PRESENT IN A BLOOD SAMPLE |
FR3001464B1 (en) | 2013-01-25 | 2016-02-26 | Biomerieux Sa | METHOD FOR SPECIFIC ISOLATION OF NUCLEIC ACIDS OF INTEREST |
JP7411948B2 (en) | 2018-03-30 | 2024-01-12 | 公立大学法人公立諏訪東京理科大学 | Clothes, heat stroke prevention system and hydration warning system |
JP7495064B2 (en) | 2019-03-13 | 2024-06-04 | 公立大学法人公立諏訪東京理科大学 | Head-mounted device, heat stroke prevention system and hydration warning system |
CN113557556B (en) | 2019-03-13 | 2023-09-08 | 公立大学法人公立诹访东京理科大学 | Head wearing device, heatstroke prevention system, and water replenishment warning system |
WO2020184688A1 (en) | 2019-03-13 | 2020-09-17 | 公立大学法人公立諏訪東京理科大学 | Head-mounted device, heat illness prevention system and hydration warning system |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3342703C2 (en) * | 1982-11-26 | 1995-10-05 | Sartorius Gmbh | Filtration device |
US4639316A (en) * | 1984-12-14 | 1987-01-27 | Becton, Dickinson And Company | Automatic liquid component separator |
US4995967A (en) * | 1987-11-06 | 1991-02-26 | Akzo N.V. | Separator for cell-containing liquids |
US4966758A (en) * | 1988-04-15 | 1990-10-30 | Becton, Dickinson And Company | Vacuum ampule filtration device |
-
1992
- 1992-11-09 US US07/973,734 patent/US5316731A/en not_active Expired - Fee Related
-
1993
- 1993-11-02 DE DE69308875T patent/DE69308875T2/en not_active Expired - Fee Related
- 1993-11-02 EP EP93925163A patent/EP0669855B1/en not_active Expired - Lifetime
- 1993-11-02 AT AT93925163T patent/ATE149880T1/en active
- 1993-11-02 JP JP51218894A patent/JP3286919B2/en not_active Expired - Fee Related
- 1993-11-02 AU AU54577/94A patent/AU667760B2/en not_active Ceased
- 1993-11-02 CA CA002146257A patent/CA2146257C/en not_active Expired - Fee Related
- 1993-11-02 DK DK93925163.3T patent/DK0669855T3/en active
- 1993-11-02 ES ES93925163T patent/ES2099984T3/en not_active Expired - Lifetime
- 1993-11-02 WO PCT/US1993/010578 patent/WO1994011107A1/en active IP Right Grant
-
1997
- 1997-05-05 GR GR970400995T patent/GR3023338T3/en unknown
Also Published As
Publication number | Publication date |
---|---|
US5316731A (en) | 1994-05-31 |
DE69308875D1 (en) | 1997-04-17 |
ATE149880T1 (en) | 1997-03-15 |
ES2099984T3 (en) | 1997-06-01 |
AU5457794A (en) | 1994-06-08 |
DK0669855T3 (en) | 1997-09-15 |
AU667760B2 (en) | 1996-04-04 |
CA2146257C (en) | 1998-07-14 |
DE69308875T2 (en) | 1997-07-03 |
JPH08511957A (en) | 1996-12-17 |
JP3286919B2 (en) | 2002-05-27 |
EP0669855A1 (en) | 1995-09-06 |
GR3023338T3 (en) | 1997-08-29 |
WO1994011107A1 (en) | 1994-05-26 |
EP0669855A4 (en) | 1996-02-14 |
CA2146257A1 (en) | 1994-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4962044A (en) | Test tube filter/dispenser apparatus and method | |
EP0669855B1 (en) | Device for collection and processing of biological samples | |
EP1581428B1 (en) | Improvement upon a cartridge for containing a specimen sample for optical analysis | |
US3957653A (en) | Apparatus for collection, separation and isolation of blood | |
US3955423A (en) | Liquid sampling method | |
US3969250A (en) | Apparatus for preparing liquid samples for analysis in automatic analyzers | |
US5976824A (en) | Method and apparatus for collecting a cell sample from a liquid specimen | |
KR100473123B1 (en) | Filtration and extraction device and method of using the same | |
US4973450A (en) | Device for urinalysis | |
US5301685A (en) | Method and apparatus for obtaining a cytology monolayer | |
US3731806A (en) | Specimen analysis device | |
US3837376A (en) | Blood serum collection tube and method | |
US5132232A (en) | Method and apparatus for preparation of liquids for examination | |
EP0730495A1 (en) | Method and apparatus for collecting a cell sample from a liquid specimen | |
US20230072999A1 (en) | Method and System for Sample Collection, Storage, Preparation and Detection | |
SK138394A3 (en) | Method for separating of liquid sample and device for realization of this method | |
US5855852A (en) | Vessel for reducing contamination in the treatment of liquids | |
EP0122581A2 (en) | Process for isolating bacteria in blood | |
US6063282A (en) | Simultaneous filtration of numerous samples using microfibers | |
NO316686B1 (en) | Method for, and device for, bonding a biological material to a solid phase, as well as combining a hollow shaped body and a probe holder | |
JP2006246835A (en) | Separation/recovery container for density gradient | |
CA1087108A (en) | Serum skimmer | |
CN113758781A (en) | Sample pretreatment device and pretreatment method | |
ITMI20002349A1 (en) | METHOD AND DEVICE FOR THE DETECTION OF BACTERIAL CHARGE IN BIOLOGICAL FLUIDS | |
KR20210069189A (en) | Microchip for sample concentration and sample concentration method using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19950505 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19951229 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
17Q | First examination report despatched |
Effective date: 19960724 |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
REF | Corresponds to: |
Ref document number: 149880 Country of ref document: AT Date of ref document: 19970315 Kind code of ref document: T |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REF | Corresponds to: |
Ref document number: 69308875 Country of ref document: DE Date of ref document: 19970417 |
|
ET | Fr: translation filed | ||
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: FIAMMENGHI-FIAMMENGHI |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: 72756 |
|
ITF | It: translation for a ep patent filed | ||
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2099984 Country of ref document: ES Kind code of ref document: T3 |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: SC4A Free format text: AVAILABILITY OF NATIONAL TRANSLATION Effective date: 19970331 |
|
REG | Reference to a national code |
Ref country code: GR Ref legal event code: FG4A Free format text: 3023338 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 19971021 Year of fee payment: 5 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 19971022 Year of fee payment: 5 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: MC Payment date: 19971024 Year of fee payment: 5 Ref country code: DK Payment date: 19971024 Year of fee payment: 5 Ref country code: AT Payment date: 19971024 Year of fee payment: 5 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 19971027 Year of fee payment: 5 Ref country code: PT Payment date: 19971027 Year of fee payment: 5 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 19971028 Year of fee payment: 5 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GR Payment date: 19971029 Year of fee payment: 5 Ref country code: DE Payment date: 19971029 Year of fee payment: 5 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 19971031 Year of fee payment: 5 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 19971106 Year of fee payment: 5 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: LU Payment date: 19971118 Year of fee payment: 5 Ref country code: BE Payment date: 19971118 Year of fee payment: 5 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IE Payment date: 19971128 Year of fee payment: 5 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981102 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981102 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981102 Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981102 Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981102 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981103 Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981103 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981130 Ref country code: GR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981130 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981130 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981130 |
|
BERE | Be: lapsed |
Owner name: CARTER-WALLACE INC. Effective date: 19981130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19990531 Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19990531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19990601 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 19981102 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19990730 |
|
EUG | Se: european patent has lapsed |
Ref document number: 93925163.3 |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee |
Effective date: 19990601 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19990901 |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: MM4A Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 19990531 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: EBP |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 19991214 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20051102 |